BioSpace News Archive

Raises 2020 Guidance to $265 Million to $275 Million in Revenues, Up from $250 Million to $260 Million, and EPS of $0.90 to $0.95, Up from $0.80 to $0.85

Halo Labs, a life science instrumentation company developing tools for biologics researchers, announced today that Rick Gordon has been named Chief Executive Officer

ALR Technologies Inc., the diabetes management company, is pleased to announce the clearance of the ALRT Diabetes Solution software by Health Canada.

INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced it has dosed its first subject with DNA medicine INO-3107 in a Phase 1/2 clinical trial for the treatment of Recurrent Respiratory Papi

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases, today announced that a webcast of Mike Raab , president and chief executive officer of Ardelyx, and Susan Rodriguez , chief commercial offic

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will present at Evercore ISI’s 3rd Annual HealthCONx Conference on Thursday, December 3 rd at 2:40

Despite an increasing need for COVID-19 care, hospitals are facing financial pressures due to the decline in outpatient and non-emerging procedures.

Pear Therapeutics, Inc. today announced that Corey McCann, M.D., Ph.D., President and CEO, will participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1 at 12:10 p.m. Eastern Time.

Ology Bioservices Inc. (Ology Bio), a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD) has awarded the company with an agreement valued at $37 million.

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of the Homechoice Claria automated peritoneal dialysis (APD) system with Sharesource connectivity platform.